Metro MN — Saint Louis Park, Minnesota

Metro MN is a clinical research site located in Saint Louis Park, Minnesota, United States 55416.

Crixeo Health Trust Score: 60/100 (FAIR). This profile has not yet been claimed by the site owner.

Metro MN has participated in 2 clinical trials with 1 currently active.

Therapeutic areas: Metastatic Breast Cancer, Non Small Cell Lung Cancer, Epidermal Growth Factor Receptor Gene Mutation.

Sponsors: PrECOG, LLC..

Sponsor Feasibility Report

Trust Score: 60/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Metro MN?

Metro MN has a Crixeo Trust Score of 60/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Metro MN conducted?

Metro MN has 2 clinical trials on record, with 1 currently active. Their work covers Metastatic Breast Cancer, Non Small Cell Lung Cancer, Epidermal Growth Factor Receptor Gene Mutation.

Is Metro MN accredited by Crixeo Health?

Metro MN has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Metro MN?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.